Report Detail
Global Carbetocin (Duratocin) Market Insights, Forecast to 2025
- RnM2379821 |
- 28 March, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
The global Carbetocin (Duratocin) market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Carbetocin (Duratocin) market based on company, product type, end user and key regions.
This report studies the global market size of Carbetocin (Duratocin) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Carbetocin (Duratocin) in these regions.
This research report categorizes the global Carbetocin (Duratocin) market by top players/brands, region, type and end user. This report also studies the global Carbetocin (Duratocin) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Beacon Pharmaceuticals Limited
Ferring Inc.
Polypeptide Laboraries France
Chemos GmbH & Co. KG
Hangzhou Dayangchem Co. Ltd.
Acinopeptide Co., Ltd.
Bachem AG
Clearsynth Canada INC.
Leap Labchem Co., Ltd
Chemieliva Pharmaceutical Co., Ltd.
Acinopeptide Co., Ltd.
BOC Sciences
Market size by Product
Tablets
Injection
Market size by End User
Oxytocic
Antihemorrhagic
Uterotonic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Carbetocin (Duratocin) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Carbetocin (Duratocin) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Carbetocin (Duratocin) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Carbetocin (Duratocin) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Carbetocin (Duratocin) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Carbetocin (Duratocin) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Carbetocin (Duratocin) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Carbetocin (Duratocin) Market Size Growth Rate by Product
- 1.4.2 Tablets
- 1.4.3 Injection
- 1.5 Market by End User
- 1.5.1 Global Carbetocin (Duratocin) Market Size Growth Rate by End User
- 1.5.2 Oxytocic
- 1.5.3 Antihemorrhagic
- 1.5.4 Uterotonic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Carbetocin (Duratocin) Market Size
- 2.1.1 Global Carbetocin (Duratocin) Revenue 2014-2025
- 2.1.2 Global Carbetocin (Duratocin) Sales 2014-2025
- 2.2 Carbetocin (Duratocin) Growth Rate by Regions
- 2.2.1 Global Carbetocin (Duratocin) Sales by Regions
- 2.2.2 Global Carbetocin (Duratocin) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Carbetocin (Duratocin) Sales by Manufacturers
- 3.1.1 Carbetocin (Duratocin) Sales by Manufacturers
- 3.1.2 Carbetocin (Duratocin) Sales Market Share by Manufacturers
- 3.1.3 Global Carbetocin (Duratocin) Market Concentration Ratio (CR5 and HHI)
- 3.2 Carbetocin (Duratocin) Revenue by Manufacturers
- 3.2.1 Carbetocin (Duratocin) Revenue by Manufacturers (2014-2019)
- 3.2.2 Carbetocin (Duratocin) Revenue Share by Manufacturers (2014-2019)
- 3.3 Carbetocin (Duratocin) Price by Manufacturers
- 3.4 Carbetocin (Duratocin) Manufacturing Base Distribution, Product Types
- 3.4.1 Carbetocin (Duratocin) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Carbetocin (Duratocin) Product Type
- 3.4.3 Date of International Manufacturers Enter into Carbetocin (Duratocin) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Carbetocin (Duratocin) Sales by Product
- 4.2 Global Carbetocin (Duratocin) Revenue by Product
- 4.3 Carbetocin (Duratocin) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Carbetocin (Duratocin) Breakdown Data by End User
6 North America
- 6.1 North America Carbetocin (Duratocin) by Countries
- 6.1.1 North America Carbetocin (Duratocin) Sales by Countries
- 6.1.2 North America Carbetocin (Duratocin) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Carbetocin (Duratocin) by Product
- 6.3 North America Carbetocin (Duratocin) by End User
7 Europe
- 7.1 Europe Carbetocin (Duratocin) by Countries
- 7.1.1 Europe Carbetocin (Duratocin) Sales by Countries
- 7.1.2 Europe Carbetocin (Duratocin) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Carbetocin (Duratocin) by Product
- 7.3 Europe Carbetocin (Duratocin) by End User
8 Asia Pacific
- 8.1 Asia Pacific Carbetocin (Duratocin) by Countries
- 8.1.1 Asia Pacific Carbetocin (Duratocin) Sales by Countries
- 8.1.2 Asia Pacific Carbetocin (Duratocin) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Carbetocin (Duratocin) by Product
- 8.3 Asia Pacific Carbetocin (Duratocin) by End User
9 Central & South America
- 9.1 Central & South America Carbetocin (Duratocin) by Countries
- 9.1.1 Central & South America Carbetocin (Duratocin) Sales by Countries
- 9.1.2 Central & South America Carbetocin (Duratocin) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Carbetocin (Duratocin) by Product
- 9.3 Central & South America Carbetocin (Duratocin) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Carbetocin (Duratocin) by Countries
- 10.1.1 Middle East and Africa Carbetocin (Duratocin) Sales by Countries
- 10.1.2 Middle East and Africa Carbetocin (Duratocin) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Carbetocin (Duratocin) by Product
- 10.3 Middle East and Africa Carbetocin (Duratocin) by End User
11 Company Profiles
- 11.1 Beacon Pharmaceuticals Limited
- 11.1.1 Beacon Pharmaceuticals Limited Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Beacon Pharmaceuticals Limited Carbetocin (Duratocin) Products Offered
- 11.1.5 Beacon Pharmaceuticals Limited Recent Development
- 11.2 Ferring Inc.
- 11.2.1 Ferring Inc. Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Ferring Inc. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Ferring Inc. Carbetocin (Duratocin) Products Offered
- 11.2.5 Ferring Inc. Recent Development
- 11.3 Polypeptide Laboraries France
- 11.3.1 Polypeptide Laboraries France Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Polypeptide Laboraries France Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Polypeptide Laboraries France Carbetocin (Duratocin) Products Offered
- 11.3.5 Polypeptide Laboraries France Recent Development
- 11.4 Chemos GmbH & Co. KG
- 11.4.1 Chemos GmbH & Co. KG Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Chemos GmbH & Co. KG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Chemos GmbH & Co. KG Carbetocin (Duratocin) Products Offered
- 11.4.5 Chemos GmbH & Co. KG Recent Development
- 11.5 Hangzhou Dayangchem Co. Ltd.
- 11.5.1 Hangzhou Dayangchem Co. Ltd. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Hangzhou Dayangchem Co. Ltd. Carbetocin (Duratocin) Products Offered
- 11.5.5 Hangzhou Dayangchem Co. Ltd. Recent Development
- 11.6 Acinopeptide Co., Ltd.
- 11.6.1 Acinopeptide Co., Ltd. Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Acinopeptide Co., Ltd. Carbetocin (Duratocin) Products Offered
- 11.6.5 Acinopeptide Co., Ltd. Recent Development
- 11.7 Bachem AG
- 11.7.1 Bachem AG Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Bachem AG Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Bachem AG Carbetocin (Duratocin) Products Offered
- 11.7.5 Bachem AG Recent Development
- 11.8 Clearsynth Canada INC.
- 11.8.1 Clearsynth Canada INC. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Clearsynth Canada INC. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Clearsynth Canada INC. Carbetocin (Duratocin) Products Offered
- 11.8.5 Clearsynth Canada INC. Recent Development
- 11.9 Leap Labchem Co., Ltd
- 11.9.1 Leap Labchem Co., Ltd Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Leap Labchem Co., Ltd Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Leap Labchem Co., Ltd Carbetocin (Duratocin) Products Offered
- 11.9.5 Leap Labchem Co., Ltd Recent Development
- 11.10 Chemieliva Pharmaceutical Co., Ltd.
- 11.10.1 Chemieliva Pharmaceutical Co., Ltd. Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Chemieliva Pharmaceutical Co., Ltd. Carbetocin (Duratocin) Products Offered
- 11.10.5 Chemieliva Pharmaceutical Co., Ltd. Recent Development
- 11.11 Acinopeptide Co., Ltd.
- 11.12 BOC Sciences
12 Future Forecast
- 12.1 Carbetocin (Duratocin) Market Forecast by Regions
- 12.1.1 Global Carbetocin (Duratocin) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Carbetocin (Duratocin) Revenue Forecast by Regions 2019-2025
- 12.2 Carbetocin (Duratocin) Market Forecast by Product
- 12.2.1 Global Carbetocin (Duratocin) Sales Forecast by Product 2019-2025
- 12.2.2 Global Carbetocin (Duratocin) Revenue Forecast by Product 2019-2025
- 12.3 Carbetocin (Duratocin) Market Forecast by End User
- 12.4 North America Carbetocin (Duratocin) Forecast
- 12.5 Europe Carbetocin (Duratocin) Forecast
- 12.6 Asia Pacific Carbetocin (Duratocin) Forecast
- 12.7 Central & South America Carbetocin (Duratocin) Forecast
- 12.8 Middle East and Africa Carbetocin (Duratocin) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Carbetocin (Duratocin) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Carbetocin (Duratocin) . Industry analysis & Market Report on Carbetocin (Duratocin) is a syndicated market report, published as Global Carbetocin (Duratocin) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Carbetocin (Duratocin) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
